Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 998,402
  • Shares Outstanding, K 665,601
  • Annual Sales, $ 990,270 K
  • Annual Income, $ -153,040 K
  • 60-Month Beta 2.39
  • Price/Sales 0.97
  • Price/Cash Flow N/A
  • Price/Book 0.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.42 +5.63%
on 01/31/20
1.67 -10.18%
on 02/06/20
-0.08 (-5.06%)
since 01/24/20
3-Month
1.42 +5.63%
on 01/31/20
1.77 -15.25%
on 01/22/20
-0.11 (-6.83%)
since 11/22/19
52-Week
1.33 +12.78%
on 10/25/19
2.88 -47.83%
on 02/26/19
-1.31 (-46.62%)
since 02/22/19

Most Recent Stories

More News
OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2019, as well as provide guidance on expected revenues and operating expenses for...

OPK : 1.50 (-7.98%)
Here's Why You Should Hold on to OPKO Health Stock for Now

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.

CHGG : 38.74 (-3.22%)
CERN : 73.38 (-3.54%)
OPK : 1.50 (-7.98%)
HQY : 82.85 (-5.56%)
Interesting OPK Call Options For September 18th

Investors in OPKO Health Inc saw new options become available this week, for the September 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...

OPK : 1.50 (-7.98%)
Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert

--Falsely Asserts Enzo Has Failed to Make Substantial Changes

ENZ : 2.20 (-2.22%)
LH : 187.55 (-1.06%)
MYGN : 18.68 (-4.94%)
OPK : 1.50 (-7.98%)
DGX : 112.34 (-0.72%)
Here's Why You Should Retain OPKO Health (OPK) Stock for Now

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.

OPK : 1.50 (-7.98%)
DXCM : 294.05 (+0.96%)
WST : 166.89 (-1.92%)
CNMD : 101.04 (-2.42%)
Watch for Opko Health to Potentially Rebound After Falling 1.31% Yesterday

Opko Health (NASDAQ:OPK) traded in a range yesterday that spanned from a low of $1.49 to a high of $1.52. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $1.51 on...

OPK : 1.50 (-7.98%)
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women's health division, GenPath Diagnostics, are pleased...

OPK : 1.50 (-7.98%)
OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

OPKO Health, Inc. (OPK) announced today that management will be participating in the 38 Annual J.P. Morgan Healthcare Conference being held January 13-16, 2020 at the Westin St. Francis in San Francisco....

JPM : 132.16 (-2.69%)
OPK : 1.50 (-7.98%)
Central Nervous System (CNS) Biomarkers Market Survey Report 2019 Along with Statistics, Forecasts till 2025

. The Central Nervous System (CNS) Biomarkers market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic...

OPK : 1.50 (-7.98%)
PMSNF : 0.0500 (+112.77%)
Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report?

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

OPK : 1.50 (-7.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade OPK with:

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

2nd Resistance Point 1.59
1st Resistance Point 1.55
Last Price 1.50
1st Support Level 1.47
2nd Support Level 1.43

See More

52-Week High 2.88
Fibonacci 61.8% 2.28
Fibonacci 50% 2.10
Fibonacci 38.2% 1.92
Last Price 1.50
52-Week Low 1.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar